Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Data In The Raw: Yale Doc Hopes Medtronic Infuse Effort Will Spark Data Transparency Model

This article was originally published in The Gray Sheet

Executive Summary

The Yale physician behind Medtronic’s recent decision to hand over all of its raw data on the embattled Infuse spinal bone graft for independent analyses and ultimate release to the broader research community sees the development as not only a smart decision for Medtronic but also as a major step forward in creating a model for the device and drug industries.

You may also be interested in...

TCT 2016: Researchers Argue For More Medtech Data Sharing

Device companies are not stepping up as much as they should be to make their raw trial data available for analysis by independent researchers, cardiologists said at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Researchers Debate Costs Of Clinical Trial Data Sharing At IOM Gathering

The costs associated with more expansive sharing of clinical trial data for independent research would be significant, experts warned at a meeting convened by the Institute of Medicine to help inform a planned study on strategies for increasing trial data-sharing.

J&J Works Toward Device Data-Sharing Agreement Following Pharma Plan

Independent researchers will be able to request access to clinical trial data for any J&J drug from clinicians at Yale’s Open Data Access Project without involvement by the company. J&J is now in discussions to set up a similar arrangement for its device and consumer products trial data.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts